Massive Hemoptysis in Cystic Fibrosis

Yankaskas, 1999, Major complications, Cystic fibrosis in adults, 175 Schidlow, 1993, Cystic Fibrosis Foundation Consensus Conference report on pulmonary complications of cystic fibrosis, Pediatr Pulmonol, 15, 187, 10.1002/ppul.1950150311 Brinson, 1998, Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis, Am J Respir Crit Care Med, 157, 1951, 10.1164/ajrccm.157.6.9708067 Barben, 2003, Major haemoptysis in children with cystic fibrosis: a 20-year retrospective study, J Cyst Fibros, 2, 105, 10.1016/S1569-1993(03)00066-3 FitzSimmons, 1993, The changing epidemiology of cystic fibrosis, J Pediatr, 122, 1, 10.1016/S0022-3476(05)83478-X Littell, 1996, SAS system for mixed models, SAS Institute. Cary, NC Corey, 1997, Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis, J Pediatr, 131, 809, 10.1016/S0022-3476(97)70025-8 Stern, 1978, Treatment and prognosis of massive hemoptysis in cystic fibrosis, Am Rev Respir Dis, 117, 825 Emerson, 2002, Pseudomonas aeruginosaand other predictors of mortality and morbidity in young children with cystic fibrosis, Pediatr Pulmonol, 34, 91, 10.1002/ppul.10127 Liou, 2001, Predictive 5-year survivorship model of cystic fibrosis, Am J Epidemiol, 153, 345, 10.1093/aje/153.4.345 Boussaud, 2003, Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secretingStaphylococcus aureus, Intensive Care Med, 29, 1840, 10.1007/s00134-003-1918-5 Naraqi, 1981, Hematogenous staphylococcal pneumonia secondary to soft tissue infection, Chest, 79, 173, 10.1378/chest.79.2.173 Loening-Baucke, 1979, A placebo-controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis, J Pediatr, 95, 630, 10.1016/S0022-3476(79)80785-4 Stutman, 2002, Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial, J Pediatr, 140, 299, 10.1067/mpd.2002.121930 Jewkes, 1983, Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment, Thorax, 38, 572, 10.1136/thx.38.8.572 Karas, 1976, Pulmonary aspergillosis: an analysis of 41 patients, Ann Thorac Surg, 22, 1, 10.1016/S0003-4975(10)63943-4 Rafferty, 1983, What happens to patients with pulmonary aspergilloma? Analysis of 23 cases, Thorax, 38, 579, 10.1136/thx.38.8.579 Nunley, 1998, Pulmonary aspergillosis in cystic fibrosis lung transplant recipients, Chest, 114, 1321, 10.1378/chest.114.5.1321 Marom, 1999, Cystic fibrosis: usefulness of thoracic CT in the examination of patients before lung transplantation, Radiology, 213, 283, 10.1148/radiology.213.1.r99oc12283 Chow, 2002, An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis, Clin Infect Dis, 35, 1, 10.1086/343743 Geller, 1999, Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics; Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis, Chest, 116, 639, 10.1378/chest.116.3.639 Knutsen, 1990, Serum immunoglobulins E and G anti-Aspergillus fumigatusantibody in patients with cystic fibrosis who have allergic bronchopulmonary aspergillosis, J Lab Clin Med, 116, 724 Krowka, 1994, Hepatopulmonary syndrome: current concepts in diagnostic and therapeutic considerations, Chest, 105, 1528, 10.1378/chest.105.5.1528 Ramsey, 1993, Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis, Am Rev Respir Dis, 148, 145, 10.1164/ajrccm/148.1.145 Ramsey, 1999, Intermittent administration of inhaled tobramycin in patients with cystic fibrosis: Cystic Fibrosis Inhaled Tobramycin Study Group, N Engl J Med, 340, 23, 10.1056/NEJM199901073400104 Cantin, 1998, DNase I acutely increases cystic fibrosis sputum elastase activity and its potential to induce lung hemorrhage in mice, Am J Respir Crit Care Med, 157, 464, 10.1164/ajrccm.157.2.9608033 Catella-Lawson, 2001, Cyclooxygenase inhibitors and the antiplatelet effects of aspirin, N Engl J Med, 345, 1809, 10.1056/NEJMoa003199 McDonald, 2001, Angiogenesis and remodeling of airway vasculature in chronic inflammation, Am J Respir Crit Care Med, 164, 15, 10.1164/ajrccm.164.supplement_2.2106065 McColley, 2000, Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation, Am J Respir Crit Care Med, 161, 1877, 10.1164/ajrccm.161.6.9905022 Holsclaw, 1970, Massive hemoptysis in cystic fibrosis, J Pediatr, 76, 829, 10.1016/S0022-3476(70)80362-6 Corey, 1987, Major and massive hemoptysis: reassessment of conservative management, Am J Med Sci, 294, 301, 10.1097/00000441-198711000-00003 Milla, 1998, Risk of death in cystic fibrosis patients with severely compromised lung function, Chest, 113, 1230, 10.1378/chest.113.5.1230